SCHEMBL1851272

SCHEMBL1851272

CC1C(=O)NCc2c(Br)cccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.50
CSNK1A1 P48729 1/20 0.50
CDK5 Q00535 1/20 0.50
ROCK1 Q13464 1/20 0.50
DYRK1A Q13627 1/20 0.50
LRRK2 Q5S007 1/20 0.50
CLK4 Q9HAZ1 1/20 0.50
DYRK1B Q9Y463 1/20 0.50
PARP10 Q53GL7 1/20 0.40
PARP11 Q9NR21 1/20 0.40
GID4 Q8IVV7 1/20 0.37
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19211033 0.75 PIM1 (0.38) PIM1CSNK1A1CDK5ROCK1DYRK1A
SCHEMBL7918368 0.74 GID4 (0.41) PIM1CSNK1A1CDK5ROCK1DYRK1A
SCHEMBL20939667 0.71 PDE7A (0.40) ALDH1A1CYP3A4CYP2D6CYP2C9LMNA
SCHEMBL1853023 0.71 PIM1 (0.34) PIM1CSNK1A1CDK5ROCK1DYRK1A
SCHEMBL30336230 0.71 GID4 (0.45) PIM1CSNK1A1CDK5ROCK1DYRK1A
SCHEMBL17682379 0.71 GID4 (0.45) PIM1CSNK1A1CDK5ROCK1DYRK1A
SCHEMBL19358117 0.71 GID4 (0.45) PIM1CSNK1A1CDK5ROCK1DYRK1A
Hydrochloric Acid SCHEMBL17671022 0.69 GID4 (0.44) PIM1CSNK1A1CDK5ROCK1DYRK1A
SCHEMBL8272671 0.69 GSK3B (0.38) ALDH1A1KDM4ECYP2D6SMN1; SMN2HTR2B
SCHEMBL1948591 0.68 HTR2A (0.44) PARP10PARP11ALDH1A1BRD4HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers MERCK SHARP & DOHME CORP. 2011-06-09 US disclosed
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers MERCK SHARP & DOHME CORP. 2011-06-09 US disclosed
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers MERCK SHARP & DOHME CORP. 2011-06-09 US disclosed
EP-2323482-A1 SUBSTITUTED DIHYDROISOQUINOLINONE AND ISOQUINOLINEDIONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS Merck & Co., Inc. (US) 2011-05-25 EP disclosed
WO-2010017048-A1 SUBSTITUTED DIHYDROISOQUINOLINONE AND ISOQUINOLINEDIONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS MERCK & CO., INC. (US) 2010-02-11 WO disclosed
WO-2010017048-A1 SUBSTITUTED DIHYDROISOQUINOLINONE AND ISOQUINOLINEDIONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS MERCK & CO., INC. (US) 2010-02-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers CACNA1D, TRPV1, CACNA1S PIM1 4392/4885CSNK1A1 689/4885CDK5 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.